Metropolitan Life Insurance CO Certara, Inc. Transaction History

Metropolitan Life Insurance CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$17.89 - $28.73 $87,356 - $140,288	-4,883 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$26.1 - $45.21 $127,446 - $220,760	4,883 New	4,883 $138,000
Q4 2021 Mar 30, 2023	BUY	$26.1 - $45.21 $44,892 - $77,761	1,720 Added 54.38%	4,883 $138,000
Q4 2021 Feb 15, 2022	BUY	$26.1 - $45.21 $44,892 - $77,761	1,720 Added 54.38%	4,883 $139,000
Q3 2021 Jun 21, 2023	BUY	$24.46 - $38.41 $94,733 - $148,761	3,873 New	3,873 $128,000
Q3 2021 Mar 30, 2023	BUY	$24.46 - $38.41 $37,815 - $59,381	1,546 Added 95.61%	3,163 $104,000
Q3 2021 Nov 15, 2021	BUY	$24.46 - $38.41 $37,815 - $59,381	1,546 Added 95.61%	3,163 $105,000
Q2 2021 Mar 30, 2023	BUY	$24.79 - $33.31 $867 - $1,165	35 Added 2.21%	1,617 $45,000
Q2 2021 Aug 16, 2021	BUY	$24.79 - $33.31 $40,035 - $53,795	1,615 Added 80750.0%	1,617 $46,000
Q1 2021 Jun 26, 2023	BUY	$25.58 - $39.0 $50,980 - $77,727	1,993 New	1,993 $54.4 Million
Q1 2021 Mar 30, 2023	BUY	$25.58 - $39.0 $40,467 - $61,698	1,582 New	1,582 $43,000
Q1 2021 May 14, 2021	BUY	$25.58 - $39.0 $51 - $78	2 New	2 $43,000

234

106M

26.4K

19.2K

Ticker CERT
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 159,899,008
Market Cap $1.66B
Description
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.